Clene (CLNN) Cash from Operations (2020 - 2025)
Clene (CLNN) posted Cash from Operations of -$4.8 million for Q4 2025, down 21.59% on a QoQ basis from -$3.9 million in Q3 2025, and up 0.56% year-over-year from -$4.8 million in Q4 2024.
Analysis
Clene (CLNN) Cash from Operations (2020 - 2025) Analysis & Trends
Clene has reported Cash from Operations for 6 years, with the latest figure at -$4.8 million in Q4 2025.
- On a quarterly basis, Cash from Operations rose 0.56% year-over-year to -$4.8 million in Q4 2025; TTM through Dec 2025 was -$18.5 million, a 13.04% increase from a year earlier, with the FY2025 full-year figure at -$18.5 million, up 13.04% from the prior year.
- Cash from Operations was -$4.8 million for Q4 2025 at Clene, down from -$3.9 million in the prior quarter.
- The five-year high for Cash from Operations was -$3.1 million in Q3 2024, with the low at -$13.1 million in Q1 2022.
- Average Cash from Operations over 5 years is -$7.2 million, with a median of -$7.2 million recorded in 2023.
- The sharpest annual moves came in 2021 and 2024: Cash from Operations sank 295.77% in 2021, then jumped 54.71% in 2024.
- Over 5 years, Cash from Operations stood at -$9.6 million in 2021, then grew by 19.73% to -$7.7 million in 2022, then rose by 6.63% to -$7.2 million in 2023, then jumped by 32.97% to -$4.8 million in 2024, then climbed by 0.56% to -$4.8 million in 2025.
- The last three Cash from Operations figures came in at -$4.8 million (Q4 2025), -$3.9 million (Q3 2025), and -$4.8 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 835.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 3.44 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | -387.32 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 507.66 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 313.60 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4.80 Mn |
| Sep 30, 2025 | -3.95 Mn |
| Jun 30, 2025 | -4.79 Mn |
| Mar 31, 2025 | -5.01 Mn |
| Dec 31, 2024 | -4.83 Mn |
| Sep 30, 2024 | -3.06 Mn |
| Jun 30, 2024 | -6.34 Mn |
| Mar 31, 2024 | -7.10 Mn |
| Dec 31, 2023 | -7.20 Mn |
| Sep 30, 2023 | -6.76 Mn |
| Jun 30, 2023 | -7.02 Mn |
| Mar 31, 2023 | -9.22 Mn |
| Dec 31, 2022 | -7.71 Mn |
| Sep 30, 2022 | -8.49 Mn |
| Jun 30, 2022 | -9.71 Mn |
| Mar 31, 2022 | -13.10 Mn |
| Dec 31, 2021 | -9.61 Mn |
| Sep 30, 2021 | -7.31 Mn |
| Jun 30, 2021 | -8.51 Mn |
| Mar 31, 2021 | -9.20 Mn |